Back to Search
MIKKAEL SEKERES, MD
MD
Hematology & Oncology Physician
NPI: 1497710941IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
ME147471(FL)
Education
OTHER
Class of 1996
Research & Publications (20)
Lenalidomide (Revlimid, CC-5013) in myelodysplastic syndromes: is it any good?
PMID 15865869·Curr Hematol Rep·2005
6-review
Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients.
PMID 18827183·Blood·2009
8-other
Targeted treatment of acute myeloid leukemia in older adults: role of gemtuzumab ozogamicin.
PMID 19503782·Clin Interv Aging·2009
6-review
Defining prior therapy in myelodysplastic syndromes and criteria for relapsed and refractory disease: implications for clinical trial design and enrollment.
PMID 19605847·Blood·2009
6-review
A prognostic scoring system for adult patients less than 60 years of age with acute lymphoblastic leukemia in first relapse.
PMID 19557633·Leuk Lymphoma·2009
8-other
Aberrant DNA methylation is a dominant mechanism in MDS progression to AML.
PMID 18832655·Blood·2009
8-other
Treatment of older adults with acute myeloid leukemia: state of the art and current perspectives.
PMID 19050066·Haematologica·2008
6-review
Poor reporting of scientific leadership information in clinical trial registers.
PMID 18286168·PLoS One·2008
8-other
Increased C-kit intensity is a poor prognostic factor for progression-free and overall survival in patients with newly diagnosed AML.
PMID 17928050·Leuk Res·2008
8-other
Relationship of treatment-related cytopenias and response to lenalidomide in patients with lower-risk myelodysplastic syndromes.
PMID 19018091·J Clin Oncol·2008
3-trial
Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML.
PMID 17954704·Blood·2008
8-other
250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies.
PMID 19074904·Cancer Res·2008
8-other
Timed sequential induction chemotherapy and risk-adapted postremission therapy for acute myelogenous leukemia.
PMID 18756545·Am J Hematol·2008
3-trial
Time to post-remission therapy is an independent prognostic factor in adults with acute lymphoblastic leukemia.
PMID 18766970·Leuk Lymphoma·2008
8-other
Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromes.
PMID 18540943·Br J Haematol·2008
3-trial
The role of AMG-531 in the treatment of thrombocytopenia in idiopathic thrombocytopenic purpura and myelodysplastic syndromes.
PMID 18549331·Expert Opin Biol Ther·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1475 NW 12TH AVE
MIAMI, FL 33136 - Phone
- (305) 243-6302
Quick Facts
- NPI
- 1497710941
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 30
- Publications
- 20
Are you this provider?
Claim Your Profile